AI-assisted framework for standardized, longitudinal CTCAE-based adverse event (AE) extraction, normalization, grading, and patient-level timeline consolidation in oncology clinical trials.
Adverse event (AE) documentation is central to safety monitoring in oncology clinical trials. However, AE identification, CTCAE mapping, grading, and attribution remain largely manual, labor-intensive, and inconsistent across visits.
We present an end-to-end LLM-assisted framework that:
- Extracts AEs from clinical notes and laboratory records
- Normalizes events to CTCAE v5.0
- Assigns severity grade and attribution
- Flags immune-related and serious AEs
- Maintains patient-level longitudinal AE trajectories
The system integrates LLM reasoning with ontology-guided semantic retrieval and deterministic grading logic to support real-world safety reporting workflows.
Adverse events in oncology trials are standardized using:
- Common Terminology Criteria for Adverse Events (CTCAE v5.0)
CTCAE defines:
- Preferred AE terms
- Severity grades (1–5)
- Standardized terminology for regulatory reporting
This framework explicitly aligns extraction and normalization to CTCAE v5.0.
- Physician progress notes
- Research nurse notes (AE listings removed)
- Structured laboratory panels
- Context-aware symptom extraction
- Temporal anchoring
- Structured JSON output
Example:
Example:
```json
[
{
"AE_term": "diarrhea",
"grade": 2,
"attribution": "Possible",
"start_date": "2024-01-12",
"end_date": "ongoing",
"immune_related": "No",
"serious": "No"
}
]- Embedding-based Top-3 retrieval
- Fine-tuned MedCPT model
- Ontology-aligned mapping
- Onset tracking
- Resolution handling
- Grade evolution across visits
- Recurrence detection